Following our in-house mining of high through-put gene expression data from public repositories, to unravel the role of the PI3K/AKT/mTOR signaling axis, and more specifically PDK1 signaling in HCC, we performed in silico proteotranscriptomic analyses of selected molecular components of the pathway in question. This evidence concerns the gene AKT1 and hepatocellular carcinoma.